@drsermedmezherexplains: “The Kiss of Death” - Myelin Edition #Breakthrough. The discovery that multiple sclerosis (MS) may be caused by the Epstein-Barr virus (EBV) has profound implications for understanding the disease and developing new therapeutic strategies. Here’s a detailed description of how this breakthrough could unlock therapeutic benefits: The Link Between EBV and Multiple Sclerosis Background on Multiple Sclerosis: Nature of the Disease: Multiple sclerosis is a chronic autoimmune condition where the immune system mistakenly attacks the myelin sheath, the protective covering of nerve fibers in the central nervous system. This leads to inflammation, demyelination, and eventual neurodegeneration, resulting in a wide range of neurological symptoms. Epstein-Barr Virus (EBV): Characteristics of EBV: EBV is a common herpesvirus that infects most people at some point in their lives, often causing infectious mononucleosis (mono). It establishes a lifelong latent infection in the host. Evidence Linking EBV to MS: Recent studies have shown a strong association between EBV infection and the development of MS. Virtually all MS patients have been previously infected with EBV, and the virus appears to play a crucial role in triggering the autoimmune response characteristic of MS. Potential Therapeutic Benefits Preventive Strategies: Vaccination: Developing a vaccine against EBV could prevent the initial infection and potentially reduce the incidence of MS. By preventing the primary trigger, a vaccine could serve as a powerful preventive measure against MS. Early Detection and Intervention: Identifying EBV infection as a risk factor for MS allows for early monitoring of individuals with EBV. Early intervention strategies could be developed to mitigate the risk of developing MS in those who are EBV-positive. #ms #brain

Dr Sermed Mezher Explains

Open In TikTok:

Region: GB

Tuesday 04 June 2024 19:23:38 GMT